Kumar, Shankar
Rao, Nikhil
Bhagwanani, Anisha
Parry, Thomas
Hameed, Maira
Rahman, Safi
Fitzke, Heather E.
Holmes, Judith
Barrow, Benjamin
Bard, Andrew
Menys, Alex
Bennett, David
Mallett, Sue
Taylor, Stuart A. https://orcid.org/0000-0002-6765-8806
Article History
Received: 23 January 2024
Revised: 4 April 2024
Accepted: 2 May 2024
First Online: 19 July 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Professor Stuart Taylor.
: The authors of this manuscript declare relationships with the following companies: B.B.: Senior Software Engineer at Motilent. A.B.: Scientific Lead at Motilent. A.M.: CEO at Motilent. D.B.: Associate Scientific Director and GI Clinical Imaging Lead at Takeda. S.A.T.: shareholder Motilent and grant funding from Takeda. The remaining authors declare that they have no competing interests.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Phase 1 of this study reported on a subset of patients from Puylaert et al []. Phase 2 reported on a subset of patients from Prezzi et al [].
: